Phathom Pharmaceuticals (PHAT) Debt to Equity (2019 - 2026)
Phathom Pharmaceuticals (PHAT) reported Debt to Equity of -$0.49 for Q1 2026, up 19.13% year-over-year from -$0.41 in Q1 2025, and down 1.79% quarter-over-quarter from -$0.48 in Q4 2025.
Phathom Pharmaceuticals (PHAT) Debt to Equity (2019 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 8 years of Debt to Equity data on file, last reported at -$0.49 in Q1 2026.
- Debt to Equity for Q1 2026 came in at -$0.49, up 19.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.49 (up 19.13% YoY), and the FY2025 annual result was -$0.48, up 39.92% from the prior year.
- Debt to Equity fell to -$0.49 in Q1 2026 per PHAT's latest filing, from -$0.48 in the prior quarter.
- Over five years, Debt to Equity peaked at $5.56 in Q2 2023 and troughed at -$13.2 in Q2 2022.
- A 5-year average of -$1.45 and a median of -$0.79 in 2024 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 730.69% in 2022 and fell as far as 3758.79% in 2022.
- A 5-year view of Debt to Equity shows it stood at -$1.27 in 2022, then tumbled by 48.78% to -$1.89 in 2023, then soared by 58.08% to -$0.79 in 2024, then surged by 39.92% to -$0.48 in 2025, then retreated by 1.79% to -$0.49 in 2026.
- Business Quant data shows PHAT's Debt to Equity at -$0.49 in Q1 2026, -$0.48 in Q4 2025, and -$0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | -0.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.49 |
| Dec 31, 2025 | -0.48 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.60 |
| Dec 31, 2024 | -0.79 |
| Sep 30, 2024 | -0.94 |
| Jun 30, 2024 | -0.75 |
| Mar 31, 2024 | -1.00 |
| Dec 31, 2023 | -1.89 |
| Sep 30, 2023 | -5.58 |
| Jun 30, 2023 | 5.56 |
| Mar 31, 2023 | -1.07 |
| Dec 31, 2022 | -1.27 |
| Sep 30, 2022 | -3.55 |
| Jun 30, 2022 | -13.20 |
| Mar 31, 2022 | 2.39 |
| Dec 31, 2021 | 1.24 |
| Sep 30, 2021 | 0.85 |
| Jun 30, 2021 | 0.36 |